Physician profile
Alejandro Garza
NPI 1073990990
$29,916.01
in general payments reported to CMS, 2019-2025
26 companies · $2,409 in 2025
The $2,409 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $570 · 2021: $1,902 · 2022: $9,557 · 2023: $13K · 2024: $2,148 · 2025: $2,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,834 · Travel and Lodging: $8,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,834.08 |
| Travel and Lodging | $8,052.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $11,048.55 | 2021-2024 | Indigo System, Benchmark, Penumbra System |
| Silk Road Medical, INC. | $3,579.68 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic, INC. | $3,328.17 | 2021-2025 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| W. L. Gore & Associates, INC. | $2,787.66 | 2020-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Cardiovascular Systems INC. | $2,358.95 | 2022-2023 | Diamondback Peripheral |
| Abbott Laboratories | $1,081.57 | 2023-2025 | Esprit, Diamondback Peripheral, Supera |
| Bard Peripheral Vascular, INC. | $921.69 | 2022-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Set Aspirex S 10f 110cm |
| Tactile Systems Technology INC | $718.45 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Endologix LLC | $555.02 | 2022-2024 | Endocross Device, Torus Stent Graft System |
| Medtronic Vascular, INC. | $445.48 | 2020 | |
| Philips North America LLC | $444.92 | 2022-2025 | (Br5) Peripheral Ivus, Pv 018 Otw, Ds Zenition 70 |
| Boston Scientific Corporation | $427.84 | 2021-2025 | General - Vascular Intervention, Opticross 35 |
| Limflow INC. | $348.21 | 2023 | Limflow System |
| Stryker Corporation | $338.99 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inari Medical, INC. | $334.86 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $299.35 | 2025 | |
| Shockwave Medical, INC | $256.97 | 2021-2022 | |
| Kerecis Limited | $132.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $114.15 | 2024 | Stratafix |
| Cook Medical LLC | $97.65 | 2022 | |
| Imperative Care, INC | $95.41 | 2023 | Symphony Catheter |
| Terumo Medical Corporation | $60.42 | 2024-2025 | Angio-Seal, Metacross Otw |
| Janssen Pharmaceuticals, INC | $57.28 | 2024 | Xarelto |
| Bolton Medical INC | $51.63 | 2023 | Treo Abdominal Stent-Graft System |
| Lemaitre Vascular, INC. | $16.72 | 2023 | Xenosure Biologic Patch |
| Angiodynamics, INC. | $13.77 | 2024 | Auryon Laser System 100-120 Vac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.